Success with antiretroviral treatment for children in Kigali, Rwanda: Experience with health center/nurse-based care

Table 3 Clinical, immunological and virological outcomes for children on antiretroviral treatment (n = 315)

	Baseline	6 months	12 months	24 months	36 months
CD4 count
< 5 years (%)^a	16	30	32	33	35
IQR	(12–19)	(23–35)	(26–34)	(28–36)	(28–40)
N	84	59	48	39	7
≥ 5 years (%)^a	13	25	26	29	29
IQR	(9–17)	(18–29)	(21–32)	(24–34)	(19–33)
N	198	175	117	80	24
≥ 5 years (abs)^a	297	550	624	704	616
IQR	(181–405)	(337–747)	(459–840)	(562–866)	(492–865)
N	217	183	120	80	24
Hb (mg/dl)^b	11.0	12.1	12.6	12.9	13.7
WAZ^a	-1.9	-1.6	-1.6	-1.5	-1.5
IQR	(-3.0;-0.9)	(-2.6;-0.8)	(-2.6;-0.7)	(-2.5;-0.6)	(-2.7;-0.6)
Viral load	Months on ART ^a		< 40 c/ml ^c	< 400 c/ml ^c	< 5000 c/ml ^c
(n = 174)	18 (15–23)		127 (73.0%)	144 (82.8%)	151 (86.8%)

^a Values are expressed as median (interquartile Range (IQR));
^b Values are expressed as median;
^c Values are expressed as n (%)
abs: absolute CD4 count (in cells/μL); Hb: hemoglobine; WAZ: Weight-for-age Z-score; ART: antiretroviral treatment

ISSN: 1471-2431